NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair, CEO and 10% owner Ron Bentsur bought $29K of Nuvectis Pharma, Inc.
Bought$28,600
$5.72Price
5,000Shares
What NVCT did for a copier
- $1,000 copied at Thu, Nov 6 open, $5.89
- $1,321
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Dec 19 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +55.3% against the S&P 500, and 7 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Nov 5. Filed Thu, Nov 6, 3:01 AM ET, before the open. Returns use the Nov 6 open and the Dec 19 close. Not investment advice.